Stéphane Champiat, Associate Professor at MD Anderson Cancer Center, shared a post on LinkedIn:
“Thrilled to share that, as part of the organizing committee, we are launching the first International Symposium on Intratumoral Immunotherapies, hosted by Gustave Roussy, on June 11–12, 2026, in Paris.
Together with colleagues from UT MD Anderson and Gustave Roussy, we’ve built a first‑of‑its‑kind, high‑impact program fully dedicated to intratumoral immunotherapies-uniting the experts, innovators, and emerging leaders who are redefining the future of local immunotherapy.
This inaugural edition is designed to spark new ideas, new collaborations, and new momentum for the field.
I hope to see you there!
Other posts featuring Stéphane Champiat.